We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$11.8B
AUM Growth
+$2.55B
Cap. Flow
+$1.85B
Cap. Flow %
15.71%
Top 10 Hldgs %
38.2%
Holding
191
New
59
Increased
40
Reduced
43
Closed
39

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$363M
2
WFC icon
Wells Fargo
WFC
+$234M
3
STZ icon
Constellation Brands
STZ
+$173M
4
CRM icon
Salesforce
CRM
+$160M
5
EQT icon
EQT Corp
EQT
+$159M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$213M
2
AMZN icon
Amazon
AMZN
+$205M
3
RICE
Rice Energy Inc.
RICE
+$157M
4
ADSK icon
Autodesk
ADSK
+$140M
5
BMY icon
Bristol-Myers Squibb
BMY
+$125M

Sector Composition

Rank Sector Weight
1 Financials 14.68%
2 Communication Services 13.99%
3 Energy 12.1%
4 Industrials 11.06%
5 Technology 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVXS
76
DELISTED
AveXis, Inc. Common Stock
AVXS
$26.4M 0.22%
273,367
-271,300
-50% -$24.5M
DVAX
77
DELISTED
Dynavax Technologies
DVAX
$26.1M 0.22%
1,211,700
-188,300
-13% -$2.98M
FOLD
78
DELISTED
Amicus Therapeutics
FOLD
$25.1M 0.21%
+1,666,900
New +$22.1M
OIBR.C
79
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
$23.5M 0.2%
3,016,780
-499,800
-14% -$3.43M
LNG icon
80
Cheniere Energy
LNG
$54.2B
$23.3M 0.2%
+516,200
New +$22.8M
ARRY
81
DELISTED
Array Biopharma Inc
ARRY
$23.2M 0.2%
+1,885,100
New +$17.5M
PRTA icon
82
Prothena Corp
PRTA
$448M
$22.8M 0.19%
352,400
+79,900
+29% +$4.89M
CDK
83
DELISTED
CDK Global, Inc.
CDK
$21.2M 0.18%
336,000
+129,600
+63% +$8.16M
NSC icon
84
Norfolk Southern
NSC
$75.4B
$19.9M 0.17%
+150,800
New +$18.3M
SRPT icon
85
Sarepta Therapeutics
SRPT
$1.64B
$18.2M 0.15%
401,000
-230,922
-37% -$9.23M
ZAYO
86
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$18.2M 0.15%
527,915
+342,015
+184% +$11.3M
EDN
87
Edenor
EDN
$1.12B
$18M 0.15%
452,550
+437,676
+2,943% +$14.7M
ACRS icon
88
Aclaris Therapeutics
ACRS
$715M
$17.7M 0.15%
686,700
-152,100
-18% -$4.08M
XYL icon
89
Xylem
XYL
$28.5B
$16.6M 0.14%
265,400
-350,300
-57% -$20.9M
I
90
DELISTED
INTELSAT S. A.
I
$16.4M 0.14%
3,484,700
-297,300
-8% -$1.12M
SIOX
91
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$16M 0.14%
290,138
+246,363
+563% +$41.6M
BIO icon
92
Bio-Rad Laboratories Class A
BIO
$8.76B
$15.2M 0.13%
+68,600
New +$15.4M
PYPL icon
93
PayPal
PYPL
$49.9B
$15.1M 0.13%
+236,113
New +$14.1M
NVCR icon
94
NovoCure
NVCR
$1.77B
$14.9M 0.13%
752,900
+420,900
+127% +$8.27M
LLL
95
DELISTED
L3 Technologies, Inc.
LLL
$14.7M 0.13%
+78,200
New +$14M
GOOG icon
96
CALL
Alphabet (Google) Class C
GOOG
$4.11T
$14.4M 0.12%
+300,000
New +$14M
WFC icon
97
CALL
Wells Fargo
WFC
$254B
$13.7M 0.12%
+248,800
New +$13.2M
NBL
98
DELISTED
Noble Energy, Inc.
NBL
$13M 0.11%
+459,100
New +$12.1M
C icon
99
CALL
Citigroup
C
$213B
$12.7M 0.11%
+174,700
New +$11.9M
ACAD icon
100
Acadia Pharmaceuticals
ACAD
$4.51B
$11.5M 0.1%
+304,600
New +$9.91M
2 3
4
5 6

Similar funds

CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
IMRF
Illinois Municipal Retirement Fund Oak Brook, Illinois $7.86B AUM 24.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
CMTU
Capital Markets Trading (UK) London, United Kingdom $7.95B AUM 85.98% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
MT
Midwest Trust Overland Park, Kansas $8.02B AUM 23.54% 1-Year Est. Return

PointState Capital's Q3 2017 Portfolio in Review

As of Q3 2017, PointState Capital held 191 positions worth $11.8B, up 28% from $9.21B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

PointState Capital deployed $1.85B of net new capital in Q3 2017, opening 59 new positions and adding to 40 existing holdings. Its largest new stake was Salesforce: 1,735,407 shares worth $162M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Energy.

On the sell side, the largest reduction was Bank of America, an estimated $213M trimmed.

  • PointState Capital's largest Q3 2017 buy was Salesforce: 1,735,407 shares worth $162M.
  • PointState Capital added most to Alphabet (Google) Class A in Q3 2017, an estimated $363M increase.
  • PointState Capital's biggest Q3 2017 reduction was Bank of America, cutting an estimated $213M.
  • PointState Capital fully exited Electronic Arts in Q3 2017, selling an estimated $109M.
  • PointState Capital's ten largest holdings make up 38% of its $11.8B portfolio in Q3 2017.
  • PointState Capital opened 59 new positions and closed 39 in Q3 2017.
  • PointState Capital's portfolio value rose 28% quarter-over-quarter to $11.8B.

Based on PointState Capital's 13F filing for Q3 2017, filed 14 Nov 2017.